Insider Stock Trading History of Spink Katharine E.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Spink Katharine E. since year 2005. The trader's CIK number is 1457130. At the time of this reporting, Spink Katharine E. is the Chief Operating Officer of Asterias Biotherapeutics, Inc. . (stock ticker symbol ASTY). See this page for all insider trading activities at Asterias Biotherapeutics, Inc. .

Note that in the past Spink Katharine E. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Spink Katharine E. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-01-09 AST Asterias Biotherapeutics, Inc. Sale 4,781 4.60 22,006
2016-12-27 AST Asterias Biotherapeutics, Inc. Option Ex 2,500 2.34 5,850
2016-12-27 AST Asterias Biotherapeutics, Inc. Sale 2,500 5.00 12,500
2016-11-23 AST Asterias Biotherapeutics, Inc. Option Ex 2,500 2.34 5,850
2016-11-23 AST Asterias Biotherapeutics, Inc. Sale 2,500 5.41 13,525
2016-11-17 AST Asterias Biotherapeutics, Inc. Sale 2,500 5.00 12,500
2016-11-17 AST Asterias Biotherapeutics, Inc. Option Ex 2,500 2.34 5,850
2016-10-06 AST Asterias Biotherapeutics, Inc. Sale 4,781 4.11 19,635
2016-09-08 AST Asterias Biotherapeutics, Inc. Sale 9,728 3.50 34,048
2016-09-09 AST Asterias Biotherapeutics, Inc. Sale 9,608 3.54 33,993
2015-09-15 AST Asterias Biotherapeutics, Inc. Sale 3,760 6.00 22,560
2011-06-14 GERN Geron Corp Sale 22,591 4.28 96,689
2011-05-24 GERN Geron Corp Sale 419 4.47 1,872
2010-06-02 GERN Geron Corp Sale 8,186 5.43 44,449
2010-05-24 GERN Geron Corp Sale 385 5.11 1,967
2009-05-29 GERN Geron Corp Sale 400 6.35 2,540
2009-05-26 GERN Geron Corp Sale 2,864 6.75 19,332

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Spink Katharine E. (Chief Operating Officer of Asterias Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.